157 related articles for article (PubMed ID: 37221222)
1. SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort.
Magavern EF; van Heel DA; ; Smedley D; Caulfield MJ
Pharmacogenomics J; 2023 Sep; 23(5):134-139. PubMed ID: 37221222
[TBL] [Abstract][Full Text] [Related]
2. Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings.
Peyser B; Perry EP; Singh K; Gill RD; Mehan MR; Haga SB; Musty MD; Milazzo NA; Savard D; Li YJ; Trujilio G; Voora D
Circ Genom Precis Med; 2018 Sep; 11(9):e002228. PubMed ID: 30354330
[TBL] [Abstract][Full Text] [Related]
3. Statin treatment effectiveness and the SLCO1B1*5 reduced function genotype: Long-term outcomes in women and men.
Türkmen D; Masoli JAH; Kuo CL; Bowden J; Melzer D; Pilling LC
Br J Clin Pharmacol; 2022 Jul; 88(7):3230-3240. PubMed ID: 35083771
[TBL] [Abstract][Full Text] [Related]
4. The frequency of major
Alrajeh K; AlAzzeh O; Roman Y
Pharmacogenomics; 2023 May; 24(7):381-398. PubMed ID: 37222158
[TBL] [Abstract][Full Text] [Related]
5.
Türkmen D; Bowden J; Masoli JAH; Melzer D; Pilling LC
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674010
[TBL] [Abstract][Full Text] [Related]
6. A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance.
Bigossi M; Maroteau C; Dawed AY; Taylor A; Srinivasan S; Melhem AL; Pearson ER; Pola R; Palmer CNA; Siddiqui MK
Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):536-545. PubMed ID: 37253618
[TBL] [Abstract][Full Text] [Related]
7. Protective Effects of Statin Therapy in Cirrhosis Are Limited by a Common SLCO1B1 Transporter Variant.
Merkel M; Schneider C; Greinert R; Zipprich A; Ripoll C; Lammert F; Reichert MC
Hepatol Commun; 2021 Oct; 5(10):1755-1766. PubMed ID: 34558822
[TBL] [Abstract][Full Text] [Related]
8. Association of statin use with cataracts: a propensity score-matched analysis.
Leuschen J; Mortensen EM; Frei CR; Mansi EA; Panday V; Mansi I
JAMA Ophthalmol; 2013 Nov; 131(11):1427-34. PubMed ID: 24052188
[TBL] [Abstract][Full Text] [Related]
9. Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms.
Linskey DW; English JD; Perry DA; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
Pharmacogenet Genomics; 2020 Dec; 30(9):208-211. PubMed ID: 32453264
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.
Cooper-DeHoff RM; Niemi M; Ramsey LB; Luzum JA; Tarkiainen EK; Straka RJ; Gong L; Tuteja S; Wilke RA; Wadelius M; Larson EA; Roden DM; Klein TE; Yee SW; Krauss RM; Turner RM; Palaniappan L; Gaedigk A; Giacomini KM; Caudle KE; Voora D
Clin Pharmacol Ther; 2022 May; 111(5):1007-1021. PubMed ID: 35152405
[TBL] [Abstract][Full Text] [Related]
11. Predictive Value of
Jansen ME; Rigter T; Fleur TMC; Souverein PC; Verschuren WMM; Vijverberg SJ; Swen JJ; Rodenburg W; Cornel MC
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833383
[TBL] [Abstract][Full Text] [Related]
12. Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial.
Vassy JL; Gaziano JM; Green RC; Ferguson RE; Advani S; Miller SJ; Chun S; Hage AK; Seo SJ; Majahalme N; MacMullen L; Zimolzak AJ; Brunette CA
JAMA Netw Open; 2020 Dec; 3(12):e2027092. PubMed ID: 33270123
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects.
Ramakumari N; Indumathi B; Katkam SK; Kutala VK
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S120-S125. PubMed ID: 30595243
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of SLCO1B1 single nucleotide variations and their association with hypercholesterolaemia in hypercholesterolemic patients in Gauteng, South Africa.
de Beer R; Outhoff K; Phulukdaree A; Soma P
Xenobiotica; 2021 Aug; 51(8):949-959. PubMed ID: 34154510
[TBL] [Abstract][Full Text] [Related]
15. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R
N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of protective haplotypes of the
Favela-Mendoza AF; Rodríguez-Rodríguez BG; Rojas-Prado E; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortés G; Rangel-Villalobos H
Per Med; 2021 Sep; 18(6):533-540. PubMed ID: 34674552
[TBL] [Abstract][Full Text] [Related]
17. SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.
Liu JE; Liu XY; Chen S; Zhang Y; Cai LY; Yang M; Lai WH; Ren B; Zhong SL
Eur J Clin Pharmacol; 2017 Nov; 73(11):1409-1416. PubMed ID: 28812116
[TBL] [Abstract][Full Text] [Related]
18. Association between rs4149056 variant in
Al-Salameh A; Danchin N; Verstuyft C; Kotti S; Puymirat E; Ferrières J; Schiele F; Coste P; Lemesle G; Cayla G; Becquemont L; Simon T
Pharmacogenomics; 2020 Feb; 21(3):163-172. PubMed ID: 31967516
[TBL] [Abstract][Full Text] [Related]
19. Statin use and cataract surgery: a nationwide retrospective cohort study in elderly ethnic Chinese patients.
Lai CL; Shau WY; Chang CH; Chen MF; Lai MS
Drug Saf; 2013 Oct; 36(10):1017-24. PubMed ID: 23771795
[TBL] [Abstract][Full Text] [Related]
20. Association between statin use and physical performance in home-dwelling older patients receiving polypharmacy: cross-sectional study.
Veddeng S; Madland H; Molden E; Wyller TB; Romskaug R
BMC Geriatr; 2022 Mar; 22(1):242. PubMed ID: 35321652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
